137 related articles for article (PubMed ID: 12906125)
1. Gene transfer in the RPE65 null mutation dog: relationship between construct volume, visual behavior and electroretinographic (ERG) results.
Ford M; Bragadóttir R; Rakoczy PE; Narfström K
Doc Ophthalmol; 2003 Jul; 107(1):79-86. PubMed ID: 12906125
[TBL] [Abstract][Full Text] [Related]
2. Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.
Narfström K; Katz ML; Bragadottir R; Seeliger M; Boulanger A; Redmond TM; Caro L; Lai CM; Rakoczy PE
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1663-72. PubMed ID: 12657607
[TBL] [Abstract][Full Text] [Related]
3. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
[TBL] [Abstract][Full Text] [Related]
4. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
[TBL] [Abstract][Full Text] [Related]
5. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
[TBL] [Abstract][Full Text] [Related]
6. In vivo gene therapy in young and adult RPE65-/- dogs produces long-term visual improvement.
Narfström K; Katz ML; Ford M; Redmond TM; Rakoczy E; Bragadóttir R
J Hered; 2003; 94(1):31-7. PubMed ID: 12692160
[TBL] [Abstract][Full Text] [Related]
7. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
[TBL] [Abstract][Full Text] [Related]
8. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
[TBL] [Abstract][Full Text] [Related]
9. Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors.
Lhériteau E; Libeau L; Mendes-Madeira A; Deschamps JY; Weber M; Le Meur G; Provost N; Guihal C; Moullier P; Rolling F
Mol Ther; 2010 Jun; 18(6):1085-93. PubMed ID: 20354505
[TBL] [Abstract][Full Text] [Related]
10. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
[TBL] [Abstract][Full Text] [Related]
11. Morphological aspects related to long-term functional improvement of the retina in the 4 years following rAAV-mediated gene transfer in the RPE65 null mutation dog.
Narfström K; Seeliger M; Lai CM; Vaegan ; Katz M; Rakoczy EP; Remé C
Adv Exp Med Biol; 2008; 613():139-46. PubMed ID: 18188938
[No Abstract] [Full Text] [Related]
12. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
[TBL] [Abstract][Full Text] [Related]
13. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.
Roman AJ; Boye SL; Aleman TS; Pang JJ; McDowell JH; Boye SE; Cideciyan AV; Jacobson SG; Hauswirth WW
Mol Vis; 2007 Sep; 13():1701-10. PubMed ID: 17960108
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.
Annear MJ; Bartoe JT; Barker SE; Smith AJ; Curran PG; Bainbridge JW; Ali RR; Petersen-Jones SM
Gene Ther; 2011 Jan; 18(1):53-61. PubMed ID: 20703309
[TBL] [Abstract][Full Text] [Related]
15. Successful gene therapy in older Rpe65-deficient dogs following subretinal injection of an adeno-associated vector expressing RPE65.
Annear MJ; Mowat FM; Bartoe JT; Querubin J; Azam SA; Basche M; Curran PG; Smith AJ; Bainbridge JW; Ali RR; Petersen-Jones SM
Hum Gene Ther; 2013 Oct; 24(10):883-93. PubMed ID: 24028205
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.
Pang JJ; Chang B; Kumar A; Nusinowitz S; Noorwez SM; Li J; Rani A; Foster TC; Chiodo VA; Doyle T; Li H; Malhotra R; Teusner JT; McDowell JH; Min SH; Li Q; Kaushal S; Hauswirth WW
Mol Ther; 2006 Mar; 13(3):565-72. PubMed ID: 16223604
[TBL] [Abstract][Full Text] [Related]
17. Assessment of structure and function over a 3-year period after gene transfer in RPE65-/- dogs.
Narfström K; Vaegan ; Katz M; Bragadottir R; Rakoczy EP; Seeliger M
Doc Ophthalmol; 2005 Jul; 111(1):39-48. PubMed ID: 16502306
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural evaluation after AAV.RPE65 gene transfer in the canine model of Leber's congenital amaurosis.
Narfström K; Bragadóttir R; Redmond TM; Rakoczy PE; van Veen T; Bruun A
Adv Exp Med Biol; 2003; 533():423-30. PubMed ID: 15180294
[No Abstract] [Full Text] [Related]
19. Phenotypic characterization of complete CSNB in the inbred research beagle: how common is CSNB in research and companion dogs?
Oh A; Loew ER; Foster ML; Davidson MG; English RV; Gervais KJ; Herring IP; Mowat FM
Doc Ophthalmol; 2018 Oct; 137(2):87-101. PubMed ID: 30051304
[TBL] [Abstract][Full Text] [Related]
20. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.
Jacobson SG; Acland GM; Aguirre GD; Aleman TS; Schwartz SB; Cideciyan AV; Zeiss CJ; Komaromy AM; Kaushal S; Roman AJ; Windsor EA; Sumaroka A; Pearce-Kelling SE; Conlon TJ; Chiodo VA; Boye SL; Flotte TR; Maguire AM; Bennett J; Hauswirth WW
Mol Ther; 2006 Jun; 13(6):1074-84. PubMed ID: 16644289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]